Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05225727 · ClinicalTrials.gov registry record · NA
Me & You-Tech: A Socio-Ecological Solution to Teen Dating Violence for the Digital Age
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 123
- Enrollment target
NCT05225727: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT05225727 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 123 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05225727, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and evaluate a multi-level (youth, parent, school) Internet-based dating violence prevention program, 'Me \& You-Tech' (MYT) for 6th-grade middle school students.
Primary Outcome
The CADRI is a 34-item questionnaire that assesses abusive behavior among adolescent dating partners (Wolfe et al., 2001). The scale has a count score ranging from 0-34. If the score is 1 or more, teen dating violence perpetration occurred. Those in the Category of "Yes" have a score of 1 or more and are considered perpetrators. Those in the Category of "No" have a score of 0 and either did not report a dating partner or reported a dating partner but did not report perpetration.
Interventions
- BEHAVIORAL Me & You - Tech
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2024-12-14 |
| Phase | NA |
What the finished NCT05225727 record still lists
NCT05225727 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Me & You - Tech is the first listed.
NCT05225727 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05225727 about?
NCT05225727 is a clinical study titled "Me & You-Tech: A Socio-Ecological Solution to Teen Dating Violence for the Digital Age". The purpose of this study is to develop and evaluate a multi-level (youth, parent, school) Internet-based dating violence prevention program, 'Me \& You-Tech' (MYT) for 6th-grade middle school students.
What is the current status of trial NCT05225727?
This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2022-10-01. Estimated completion is 2024-12-14.
What interventions are being tested in trial NCT05225727?
The interventions under investigation include: Me & You - Tech (BEHAVIORAL).
Who is sponsoring clinical trial NCT05225727?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05225727's enrollment target sits among peer trials
123 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI